FDA Orange Book · active-ingredient family
Magnesium acetate tetrahydrate; potassium acetate; sodium chloride
Magnesium acetate tetrahydrate; potassium acetate; sodium chloride is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:PLASMA-LYTE 56 IN PLASTIC CONTAINER · NDA 019047
1
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PLASMA-LYTE 56 IN PLASTIC CONTAINER | BAXTER HLTHCARE | NDA 019047 | — | Jun 15, 1984 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Magnesium acetate tetrahydrate; potassium acetate; sodium chloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
